Dalton is a contract pharmaceutical manufacturer which provides integrated chemistry, development, and manufacturing to biotechnology and pharmaceutical clients around the world. In its 42,000 sq. ft. facility, Dalton operates - cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), - sterile injectables, - finished drug products in vials or syringes - solid oral dosage forms. APIs can be produced in gram to kilogram quantities, including sterile APIs. Dalton contract capabilities can support you at any stage of the regulatory process (Phase I, II, III, or commercial). Development services include - chemistry and process development, - medicinal chemistry, - custom drug conjugation, - targeted drug delivery systems, - analytical method development and validation, - ICH stability testing, - formulation, and - polymorphism screening. Dalton also supports the industry's pharmaceutical research programs with a catalog of 2,500 reference standards, building blocks, metabolites, and impurities with its Dalton Research Molecules division.
Looking for a particular Dalton Pharma Services employee's phone or email?
The Dalton Pharma Services annual revenue was $40.2 million in 2026.
Jixing Wang is the President of Dalton Pharma Services.
121 people are employed at Dalton Pharma Services.
Dalton Pharma Services is based in Toronto, Ontario.
The NAICS codes for Dalton Pharma Services are [32, 32541, 3254, 325].
The SIC codes for Dalton Pharma Services are [283, 28].